Low alkaline phosphatase levels: a potential indicator of Wilson disease

Jagadish Ramasamy; Aarathy Dhanapalan; Deepak James

doi:10.18203/2320-6012.ijrms20254000

Authors

Jagadish Ramasamy Department of Biochemistry, All India Institute of Medical Sciences, Madurai, Tamil Nadu, India
Aarathy Dhanapalan Department of Biochemistry, Government Theni Medical College, Theni, Tamil Nadu, India
Deepak James Department of Gastroenterology, Velammal Medical College Hospital and Research Institute, Madurai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20254000

Keywords:

Wilson disease, Alkaline phosphatase, Total Bilirubin, Copper, Ceruloplasmin

Abstract

A young adult female patient presented with complaints of jaundice, intermittent vomiting, and weight loss. Upon examination, pedal oedema and abdominal distension were observed. Laboratory investigations indicated macrocytic anaemia, hemolysis, prolonged prothrombin time, mixed hyperbilirubinemia, elevated aspartate/alanine transaminase (AST/ALT), and a normal alkaline phosphatase (ALP). The investigations repeated showed an increase in bilirubin, AST, and ALT. However, the levels of ALP and the ALP: total bilirubin ratio (ALP:TB ratio) were found to be very low. This raised the suspicion of Wilson disease, and further laboratory workup was initiated. Urine (24-hour) and serum copper levels were elevated, while serum ceruloplasmin levels were lower. Based on this, the diagnosis of acute on chronic liver failure (ACLF) related to Wilson disease was made. The levels of ALP and the ALP:TB ratio remained low until the sixth day. This report demonstrates the clinical relevance of low levels of ALP and ALP: TB ratio and its diagnostic utility in establishing the diagnosis of Wilson disease.

Metrics

Metrics Loading ...

References

Taly AB, Prashanth LK, Sinha S. Wilson’s disease: An Indian perspective. Neurol India. 2009;57(5):528–40. DOI: https://doi.org/10.4103/0028-3886.57789

Prashanth L, Taly A, Sinha S, Arunodaya G, Swamy H. Wilson’s disease: diagnostic errors and clinical implications. J Neurol Neurosurg Psychiatry. 2004 June;75(6):907–9. DOI: https://doi.org/10.1136/jnnp.2003.026310

Immergluck J, Grant LM, Anilkumar AC. Wilson Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available at: http://www.ncbi.nlm.nih.gov/books/NBK441990/. Accessed on 21 August 2025.

Schilsky ML, Roberts EA, Bronstein JM, Dhawan A, Hamilton JP, Rivard AM, et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology. 2023;77(4):1428. DOI: https://doi.org/10.1002/hep.32805

Iluz-Freundlich D, Grubert Van Iderstine M, Uhanova J, Zhang M, Knowles C, Minuk GY. Low serum alkaline phosphatase levels in patients with chronic liver diseases: Possible contributions to disease pathogenesis. Clin Res Hepatol Gastroenterol. 2021;45(4):101694. DOI: https://doi.org/10.1016/j.clinre.2021.101694

Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7(1):378. DOI: https://doi.org/10.1038/s41392-022-01229-y

Shaver WA, Bhatt H, Combes B. Low serum alkaline phosphatase activity in Wilson’s disease. Hepatol Baltim Md. 1986;6(5):859–63. DOI: https://doi.org/10.1002/hep.1840060509

Korman JD, Volenberg I, Balko J, Webster J, Schiodt FV, Squires RH, et al. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatol Baltim Md. 2008;48(4):1167–74. DOI: https://doi.org/10.1002/hep.22446

Csopak H, Falk KE. The specific binding of copper(II) to alkaline phosphatase of E. coli. FEBS Lett. 1970;7(2):147–50. DOI: https://doi.org/10.1016/0014-5793(70)80142-9

Eisenbach C, Sieg O, Stremmel W, Encke J, Merle U. Diagnostic criteria for acute liver failure due to Wilson disease. World J Gastroenterol WJG. 2007;13(11):1711–4. DOI: https://doi.org/10.3748/wjg.v13.i11.1711

Feng CX, Chen XQ, He XL, Lan LC, Tang Q, Huang L, et al. Screening for Wilson’s disease in acute liver failure: A new scoring system in children. Front Pediatr. 2025. Available at: https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2022.1003887/full. Accessed on 21 August 2025.

Pandey N, Blair K, John S. Kayser-Fleischer Ring. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available at: http://www.ncbi.nlm.nih.gov/books/NBK459187/. Accessed on 21 August 2025.

Deiss A, Lee G, Cartwright G. Hemolytic Anemia in Wilson’s Disease. Ann Intern Med. 1970;73(3):413–8. DOI: https://doi.org/10.7326/0003-4819-73-3-413